H Mahteme
Overview
Explore the profile of H Mahteme including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cashin P, Mahteme H, Syk I, Frodin J, Glimelius B, Graf W
Eur J Surg Oncol
. 2018 Mar;
44(7):983-990.
PMID: 29530346
Background: The aim was to compare health-related quality-of-life (HRQOL) and cost-effectiveness between cytoreductive surgery with intraperitoneal chemotherapy (CRS + IPC) and systemic chemotherapy for patients with colorectal peritoneal metastases. Methods:...
2.
Cashin P, Mahteme H, Spang N, Syk I, Frodin J, Torkzad M, et al.
Eur J Cancer
. 2016 Jan;
53:155-62.
PMID: 26751236
Background: First-line treatment of isolated resectable colorectal peritoneal metastases remains unclear. This study (the Swedish peritoneal study) compares cytoreductive surgery and intraperitoneal chemotherapy (surgery arm) with systemic chemotherapy (chemotherapy arm)....
3.
Torkzad M, Casta N, Bergman A, Ahlstrom H, Pahlman L, Mahteme H
J Surg Oncol
. 2015 Jan;
111(6):746-51.
PMID: 25580825
Background: To compare CT and MRI for peritoneal carcinomatosis index (PCI) assessment and to compare assessments made by the radiologist based on their experiences. Method And Materials: MRI and CT...
4.
Andreasson H, Lorant T, Pahlman L, Graf W, Mahteme H
Eur J Surg Oncol
. 2014 Mar;
40(8):930-6.
PMID: 24656455
Background: Cytoreductive surgery (CRS) plus perioperative intraperitoneal chemotherapy is a highly invasive treatment of peritoneal metastasis and requires many surgical procedures before mastering. The aim of this study was to...
5.
Cashin P, Ehrsson H, Wallin I, Nygren P, Mahteme H
Eur J Clin Pharmacol
. 2012 Sep;
69(3):533-40.
PMID: 22983312
Purpose: Cisplatin during hyperthermic intraperitoneal chemotherapy (HIPEC) has not previously been measured with a selective technique. The primary aims were to examine the pharmacokinetics of active cisplatin and its monohydrated...
6.
Andreasson H, Graf W, Nygren P, Glimelius B, Mahteme H
Eur J Surg Oncol
. 2012 Jul;
38(10):962-8.
PMID: 22809859
Background: The aim of this study was to compare debulking surgery and cytoreductive surgery (CRS) in patients with Pseudomyxoma peritonei (PMP) regarding efficacy and safety. Patients And Methods: Data were...
7.
Cashin P, Graf W, Nygren P, Mahteme H
Eur J Surg Oncol
. 2012 Apr;
38(6):509-15.
PMID: 22475555
Background: Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) treatment of colorectal peritoneal carcinomatosis (PC) is gaining acceptance, but controversy remains. The primary aims were to analyse the outcome and prognostic...
8.
Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A
Br J Surg
. 2012 Jan;
99(5):699-705.
PMID: 22287157
Background: This was a population-based cohort study to determine the incidence, prevalence and risk factors for peritoneal carcinomatosis (PC) from colorectal cancer. Methods: Prospectively collected data were obtained from the...
9.
Arakelian E, Gunningberg L, Larsson J, Norlen K, Mahteme H
Eur J Surg Oncol
. 2011 Jul;
37(10):897-903.
PMID: 21783337
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can prolong survival in selected patients with peritoneal carcinomatosis (PC). However, there is little data on patients' recovery process after...
10.
Cashin P, Graf W, Nygren P, Mahteme H
Ann Oncol
. 2011 Jun;
23(3):647-652.
PMID: 21685413
Background: Cytoreductive surgery and intraperitoneal chemotherapy has improved prognosis in patients with peritoneal carcinomatosis. The main modes of intraperitoneal chemotherapy treatment are peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) and normothermic sequential...